HKSE - Delayed Quote HKD
Immunotech Biopharm Ltd (6978.HK)
3.590
-0.030
(-0.83%)
As of 3:05:45 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
169,411
169,411
224,333
268,830
335,590
Operating Income
-169,411
-169,411
-224,333
-268,830
-335,590
Net Non Operating Interest Income Expense
-6,422
-6,422
-5,510
-2,934
3,878
Pretax Income
-186,417
-186,417
-335,479
-321,095
-354,615
Tax Provision
926
926
0
0
0
Net Income Common Stockholders
-186,912
-186,912
-334,819
-318,109
-354,224
Diluted NI Available to Com Stockholders
-186,912
-186,912
-334,819
-318,109
-354,224
Basic EPS
-0.60
-0.36
-0.65
-0.62
-0.69
Diluted EPS
-0.60
-0.36
-0.65
-0.62
-0.69
Basic Average Shares
514,584
514,584
514,584
514,584
514,584
Diluted Average Shares
514,584
514,584
514,584
514,584
514,584
Rent Expense Supplemental
16,135
--
--
--
--
Total Expenses
169,411
169,411
224,333
268,830
335,590
Net Income from Continuing & Discontinued Operation
-186,912
-186,912
-334,819
-318,109
-354,224
Normalized Income
-133,839
-133,839
-245,189
-293,198
-336,641
Interest Income
1,071
1,071
3,009
3,201
7,556
Interest Expense
7,493
7,493
8,519
6,135
3,678
Net Interest Income
-6,422
-6,422
-5,510
-2,934
3,878
EBIT
-178,924
-178,924
-326,960
-314,960
-350,937
EBITDA
-118,052
-118,052
-273,561
-270,889
-329,932
Reconciled Depreciation
60,872
60,872
53,399
44,071
21,005
Net Income from Continuing Operation Net Minority Interest
-186,912
-186,912
-334,819
-318,109
-354,224
Total Unusual Items Excluding Goodwill
-70,764
-70,764
-89,630
-24,911
-17,583
Total Unusual Items
-70,764
-70,764
-89,630
-24,911
-17,583
Normalized EBITDA
-47,288
-47,288
-183,931
-245,978
-312,349
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-17,691
-17,691
0
0
0
12/31/2021 - 7/10/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade